SecProbe.io - Probe Score Transparency

Probe Score Transparency

Spyre Therapeutics, Inc. (SYRE)
Score window: Apr. 15, 2025 to Apr. 14, 2026

Back View Correspondence

Probe Score

3.5 / 10

Letters

2

Latest Activity

Jun. 2, 2025

Version

v1

Score Breakdown

Letter Count

2.0

Sentiment / Tone

1.5

Keywords

0.0

Signals

0.0

Notable 8-K Modifier

0.0

Notable 8-K Count

0

Matched Signals

No stored keyword or signal matches were recorded for this score.

Filings In This Window

Date	Form	Sentiment	Urgency	Summary	Open
Jun. 2, 2025	UPLOAD	Neutral/Informational	Low	The SEC has completed its review of Spyre Therapeutics, Inc.'s Form 10-K for the fiscal year ended December 31, 2024. They remind the company that it is ultimately responsible for…	Read Filing EDGAR
May. 21, 2025	CORRESP	Neutral/Informational	Moderate	The correspondence from Spyre Therapeutics, Inc. addresses comments from the SEC regarding their Form 10-K for the fiscal year ended December 31, 2024. The SEC requested more deta…	Read Filing EDGAR
May. 9, 2025	UPLOAD	Concern from SEC	High	The SEC has issued a comment letter to Spyre Therapeutics regarding their Form 10-K for the fiscal year ended December 31, 2024. The SEC is specifically requesting more detailed d…	Read Filing EDGAR

Notable 8-Ks In This Window

No notable 8-Ks were stored for this company in the score window.